Table 2.
Safety and performance parameters
| Assessment | Purpose | Follow-up timepoints | Evaluator |
|---|---|---|---|
| Angiography | To assess vessel patency | Baseline, procedure, and sacrifice (90 days) | Independent board-certified radiologist |
| Animal health | To assess animal health for any clinically significant observations | Monitored throughout the study duration through sacrifice (90 days) | Independent board-certified veterinarian |
| Clinical pathology (bloodwork) |
To assess hematology and serum chemistry values related to animal health, including: • Liver • Pancreas • Kidney function |
Pre-treatment, intermediate time point (30 days) and at sacrifice (90 days) | Independent board-certified veterinarian |
| Gross pathology (necropsy) |
To assess any gross abnormalities, including: • Hepatic parenchyma of all liver lobes • Head, body, and tail of the pancreas • Proximal duodenum • Gall bladder • Kidneys • Small bowel • Psoas muscle adjacent to the renal arteries |
At sacrifice (90 days) | Independent board-certified veterinary pathologist |
| Histopathology of the treatment area (renal arteries, common hepatic artery and surrounding tissues) |
To assess: • Morphologic characterization of treatment area, including depth and circumferentiality • Vessel wall injury • Perivascular injury |
At sacrifice (90 days) | Independent board-certified veterinary pathologist |
| Norepinephrine assessment | To assess denervation of the liver, kidneys and adjacent organs (pancreas and duodenum) | At sacrifice (90 days) | Independent test laboratory |